INVN Stock DD InvenSense, Inc. 08/05/2014 16:57:13

New Post Public Reply Private Reply Replies (0) Message Board

Aug 5, 2014 at 5:57 PM

INVN InvenSense, Inc. $INVN Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=INVN&...mp;yt0=Go!

Last Updated: 08/05/2014 16:57:09

Current Price and Quotes
Last Price 23.50
Previous Close 22.98 Open 22.76
Daily Range 22.53 - 23.62 52wk Range 15.20 - 26.78
Volume 2,182,711 Dividend N/A
Average Vol (3m) 2,435,069 Yield N/A

Financials
Period Ending Mar 30, 2014 Mar 31, 2013 Apr 01, 2012 Apr 03, 2011
Total Revenue 252,533 208,634 152,967 96,547
Cost of Revenue 127,724 97,937 67,571 43,647
Gross Profit 124,809 110,697 85,396 52,900
Operating Expenses

Research and Development 48,431 24,648 19,672 15,826
Sales, General and Admin. 51,344 29,391 18,710 15,596
Non-Recurring Items 15,000 - - -
Other - - - -
Operating Income 10,034 56,658 47,014 21,478
Income From Continuing Operations

Add'l Income/Expense Items 167 350 160 (3,994)
Earnings Before Interest and Tax 10,201 57,008 47,174 17,484
Interest Expense 4,012 2 22 -
Earnings Before Tax 6,189 57,006 47,152 17,484
Income Tax 70 5,301 10,205 8,137
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 6,119 51,705 36,947 9,347
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 6,119 51,705 36,947 9,347
Preferred Stock and Other Adjustments - - (20,618) (7,716)
Net Income Applicable to Common Shareholders 6,119 51,705 16,329 1,631

Recent News

Aug 5, 2014 Critical Alerts For Achillion Pharmaceuticals, Synergy Resources, Invensense, JinkoSolar, and Harley-Davidson Released By InvestorsObserver
Jul 29, 2014 InvenSense Announces First Quarter Fiscal Year 2015 Result
Jul 21, 2014 InvenSense Schedules First Quarter FY2015 Results Conference Call For July 29, 2014 at 1:30PM PST
Jul 17, 2014 Information Technology Stocks Technical Data: ParkerVision, Ubiquiti Networks, ShoreTel, InvenSense, and Knowles
Jul 14, 2014 Critical Alerts For InvenSense, Google, FireEye, Cisco Systems, and Wells Fargo Released By InvestorsObserver
Jul 7, 2014 InvenSense To Acquire Movea, A Leading Provider Of Ultra-Low Power Motion And Data Fusion Software Platforms And Trusted Positioning, Inc., A Leader In Indoor/Outdoor Location Technology
Jun 26, 2014 New Reservation Systems, Product Launches, and Enhanced Capabilities - Analyst Notes on MICROS Systems, InvenSense, Ruckus Wireless, DealerTrack Technologies and Sapient
Jun 11, 2014 InvenSense Unveils World's Best-In-Class Consumer Gyroscope for High Speed Motion and Wearable Applications
Jun 10, 2014 Critical Alerts For Starbucks, Organovo, Burger King, Invensense, and NRG Energy Technology Released By InvestorsObserver
Jun 6, 2014 Technical Recap on Information Technology Equities -- Research on Parkervision, InvenSense, International Rectifier, and Silicon Laboratories

1
2
next >

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...